(RTTNews) - AVITA Medical, Inc. (RCEL), a regenerative medicine company focused on innovative wound care solutions, announced that the U.S. Food and Drug Administration has approved its premarket ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback